Maeurer MJ - Search Results

1

Systems level immune response analysis and personalized medicine.

Brodin P, Valentini D, Uhlin M, Mattsson J, Zumla A, Maeurer MJ. Brodin P, et al. Among authors: maeurer mj. Expert Rev Clin Immunol. 2013 Apr;9(4):307-17. doi: 10.1586/eci.13.9. Expert Rev Clin Immunol. 2013. PMID: 23557267 Review.

2

Adjunct immunotherapies for tuberculosis.

Uhlin M, Andersson J, Zumla A, Maeurer M. Uhlin M, et al. J Infect Dis. 2012 May 15;205 Suppl 2:S325-34. doi: 10.1093/infdis/jis197. Epub 2012 Mar 29. J Infect Dis. 2012. PMID: 22457298 Review.

3

Intravenous immunoglobulin (IVIg) for refractory and difficult-to-treat infections.

Ferrara G, Zumla A, Maeurer M. Ferrara G, et al. Am J Med. 2012 Oct;125(10):1036.e1-8. doi: 10.1016/j.amjmed.2012.01.023. Epub 2012 May 16. Am J Med. 2012. PMID: 22608788 Review.

4

H1N1 viral proteome peptide microarray predicts individuals at risk for H1N1 infection and segregates infection versus Pandemrix(®) vaccination.

Ambati A, Valentini D, Montomoli E, Lapini G, Biuso F, Wenschuh H, Magalhaes I, Maeurer M. Ambati A, et al. Immunology. 2015 Jul;145(3):357-66. doi: 10.1111/imm.12448. Epub 2015 Apr 15. Immunology. 2015. PMID: 25639813 Free PMC article.

5

Host directed therapies (HDTs) and immune response signatures: insights into a role for interleukin-32.

Maeurer M, Rao M, Zumla A. Maeurer M, et al. Ann Transl Med. 2015 May;3(Suppl 1):S37. doi: 10.3978/j.issn.2305-5839.2015.03.65. Ann Transl Med. 2015. PMID: 26046084 Free PMC article. No abstract available.

6

B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis.

Rao M, Valentini D, Poiret T, Dodoo E, Parida S, Zumla A, Brighenti S, Maeurer M. Rao M, et al. Clin Infect Dis. 2015 Oct 15;61Suppl 3(Suppl 3):S225-34. doi: 10.1093/cid/civ614. Clin Infect Dis. 2015. PMID: 26409285 Free PMC article. Review.

7

Strong anti-Epstein Barr virus (EBV) or cytomegalovirus (CMV) cellular immune responses predict survival and a favourable response to anti-tuberculosis therapy.

Nagu T, Aboud S, Rao M, Matee M, Axelsson R, Valentini D, Mugusi F, Zumla A, Maeurer M. Nagu T, et al. Int J Infect Dis. 2017 Mar;56:136-139. doi: 10.1016/j.ijid.2017.01.022. Epub 2017 Feb 11. Int J Infect Dis. 2017. PMID: 28193504 Free article.

8

Update on viral infections in lung transplantation.

Uhlin M, Mattsson J, Maeurer M. Uhlin M, et al. Curr Opin Pulm Med. 2012 May;18(3):264-70. doi: 10.1097/MCP.0b013e3283521066. Curr Opin Pulm Med. 2012. PMID: 22388587 Review.

9

Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis.

Valentini D, Ferrara G, Advani R, Hallander HO, Maeurer MJ. Valentini D, et al. Among authors: maeurer mj. BMC Immunol. 2015 Jul 1;16:40. doi: 10.1186/s12865-015-0090-3. BMC Immunol. 2015. PMID: 26129684 Free PMC article.

10

Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosis.

Rao M, Valentini D, Zumla A, Maeurer M. Rao M, et al. Int J Infect Dis. 2018 Apr;69:78-84. doi: 10.1016/j.ijid.2018.02.021. Epub 2018 Mar 2. Int J Infect Dis. 2018. PMID: 29501835 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters